F32 F33 F34 F43.2
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients (m/f/d) with depressive symptoms (depression diagnosis , ICD-10: F32-F34 or F 43.2) aged 18 to 70 years as well as control subjects without depressive symptoms, also aged 18-70 years. Depression symptomatology will be assessed via the study questionnaires (PHQ-2, BDI-II), subjects who do not reach the cut-off value will be assigned to the control group.
Exclusion criteria
Exclusion criteria: - COVID-19 disease in infectious phase or symptoms suggestive of COVID-19 disease. - Employee of the Clinical Institute of Psychosomatic Medicine and Psychotherapy. - Last alcohol consumption less than 8 hours ago - insufficient knowledge of the German language - uncorrected visual loss and visual disturbances - neurological/psychiatric pre-existing diseases, especially those affecting the vestibular organ impairing the sense of balance or altering visual perception - taking medications that affect eye movements (Lithium, carbamazepine, lamotrigine, topiramate, phenytoin, risperidone, haloperidol, phenobarbital, or primidone, and the use of benzodiazepines in the past 24 hours) - claustrophobia - prosopagnosia - a body mass index (BMI) less than or equal to 17
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total fixation time (TFT), measured with an Eyetracker included in the VR-glases during the experiment, physiological measurement | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of fixations (NoF), measured with an Eyetracker included in the VR-glases during the experiment, physiological measurement | — |
Countries
Germany
Contacts
Universitätsklinikum Düsseldorf, Klinisches Institut für Psychosomatische Medizin und Psychotherapie